"Freeman Cornell-Beshore Cancer Institute brings together the many services necessary to provide comprehensive care for patients and families dealing with cancer."

During the past decade, Freeman Cancer Institute at Freeman Health System conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 12 clinical trials were completed, i.e. on average, 240% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 4 clinical trials were completed. i.e. 400% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Freeman Cancer Institute at Freeman Health System" #1 sponsor was "SWOG Cancer Research Network" with 8 trials, followed by "NSABP Foundation Inc" with 5 trials sponsored, "Eli Lilly and Company" with 3 trials sponsored, "Alliance for Clinical Trials in Oncology" with 1 trials sponsored and "Daiichi Sankyo, Inc." with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Freeman Cancer Institute at Freeman Health System" #1 collaborator was "National Cancer Institute (NCI)" with 15 trials as a collaborator, "NCIC Clinical Trials Group" with 3 trials as a collaborator, "AstraZeneca" with 2 trials as a collaborator, "Cancer and Leukemia Group B" with 2 trials as a collaborator and "North Central Cancer Treatment Group" with 2 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Freeman Cancer Institute at Freeman Health System" are "Breast Cancer" (10 trials), "Breast Neoplasms" (2 trials), "Lung Cancer" (2 trials), "Cardiac Toxicity" (1 trials) and "Chemotherapy-induced Nausea and Vomiting" (1 trials). Many other conditions were trialed in "Freeman Cancer Institute at Freeman Health System" in a lesser frequency.

Most popular intervention types in "Freeman Cancer Institute at Freeman Health System" are "Drug" (22 trials), "Biological" (3 trials), "Other" (3 trials), "Radiation" (3 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Abemaciclib" (3 trials), "Placebo" (3 trials), "cyclophosphamide" (3 trials), "placebo" (3 trials) and "Trastuzumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Freeman Cancer Institute at Freeman Health System" are 13 trials for "All" genders, 10 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Freeman Cancer Institute at Freeman Health System". undefined are not yet recruiting, undefined are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Freeman Cancer Institute at Freeman Health System, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Freeman Cancer Institute at Freeman Health System, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".